BioCentury
ARTICLE | Clinical News

AB-1001: Phase I start

February 6, 2006 8:00 AM UTC

Abeille started an open-label, 3-month, 3-way crossover, U.S. Phase I trial in 12 healthy volunteers to compare 2 doses of AB-1001 patch with IV administration of the product. ...